Neelabh Datta

Mr. Neelabh Datta


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2024 in Cell Therapy & Engineering Connect
Verified
Journal Article
Open access
PDF file
Neelabh DattaNeelabh Datta
Neelabh Datta
The therapeutic potential of biomacromolecules in treating various diseases is undeniable; however, their application is significantly limited by the inherent barrier function of the cell membrane. Cell-penetrating peptides (CPPs), a class of small peptides comprising fewer than 30 amino acids, have garnered considerable attention due to their exceptional ability to traverse cell membranes. These peptides ease the intracellular delivery of various macromolecules, such as proteins, polypeptides, and nucleic acids, thereby overcoming the limitations imposed by the plasma membrane. CPPs exhibit versatile translocation properties, allowing them to penetrate cells independently and serve as delivery vehicles for therapeutic agents or CPP/cargo complexes. This unique capability has positioned them as promising candidates in treating and diagnosing diseases, including cancer. Their ability to transport biologically active molecules across the plasma membrane enhances the efficacy of therapeutic interventions that would otherwise face significant challenges due to poor cellular uptake. This review explores the classification of CPPs based on their structure and properties, shedding light on the mechanisms that enable their efficient membrane penetration. It also touches on various therapeutic applications of CPPs, emphasizing their potential to revolutionize drug delivery systems. Despite their promise, the clinical utility of CPPs is hindered by challenges such as stability, specificity, and potential cytotoxicity. Addressing these limitations is crucial to unlocking the full potential of CPPs as innovative delivery tools in modern medicine.

1 January 2023 in AIMS Biophysics
Verified
Journal Article
Open access
PDF file
Neelabh DattaNeelabh Datta
Neelabh Datta
In humans particularly in children, adenovirus is one of the most common viruses that cause respiratory illnesses. Knowing how to detect adenovirus proficiently and rapidly will help reinforce surveillance of adenovirus infections, detect epidemic situations in real-time, and understand the trend of virus epidemics, which will allow effective actions to be taken quickly. The rapid detection of antiviral antibodies or viral antigens in clinical samples can be achieved by molecular diagnostic techniques like PCR, Real-Time PCR, LAMP, mPCR-RLB, PCR-ELISA, Tem-PCR, Gene Chip, and so on. Some of the molecular diagnostic methods are relatively economical, exceedingly sensitive and explicit. There are several commercially accessible molecular diagnostic techniques that enable their use in clinical laboratories all over the world. In this review, the principles, characteristics, and applications of molecular biology surveillance methods commonly used in labs and clinics for the detection of human adenoviruses are examined and highlighted.

8 March 2024 in University of Michigan Undergraduate Research Journal
Verified
Journal Article
Open access
PDF file
Neelabh DattaNeelabh Datta
Neelabh Datta
The revolutionary realm of molecular cloning, encompassing the creation of recombinant DNA molecules, has ignited a wave of progress within the life sciences. The advent of potent tools has facilitated the manipulation of DNA, resulting in an extraordinary surge in the versatility and breadth of applications in recombinant DNA technology. The once complex task of cloning genes has now been simplified, triggering a veritable explosion of insights into gene functionality. This has been achieved through the seamless fusion of multiple DNA fragments or the utilization of interchangeable gene cassettes, culminating in a state of unparalleled agility and expediency. In the 1970s, when restriction endonucleases, enzymes that cut DNA molecules selectively were discovered, molecular cloning technology has grown exponentially in application and intricacy, resulting in influential DNA manipulation tools. Recent decades have seen an explosion in our understanding of gene function due to the simplicity and efficiency of molecular cloning. It is expected that emerging technologies will offer superior potentials, such as stitching together multiple DNA fragments in under a few hours and transforming the resulting plasmids into bacteria, or the use of swappable genes, which can be easily moved between different paradigms, maximizing promptness and flexibility. It has been proved that cloning techniques provide a gold standard technique for polymicrobial infection, recombinant cytokines, antimicrobial peptides, epidemiology and gene therapy due to the limitations of culture-based methods. Due to molecular cloning technique, recombinant antigens are now being used to monitor patients against clinical infections. As a result of laboratory techniques that permit in vitro chemical synthesis of any DNA construct specified in silico, molecular cloning will likely undergo a paradigm shift in the coming future. As a result of these advances, DNA clones can be constructed faster and iteratively, which will speed up the growth of new vaccines, gene therapy vectors, and recombinant proteins. Here I present a detailed overview of the latest applications of molecular cloning techniques in medical microbiology.

1 June 2023 in Acta Biologica Marisiensis
Verified
Journal Article
Open access
PDF file
Neelabh DattaNeelabh Datta
Neelabh Datta
There have been significant advances in our understanding of how changes in the fluidity and permeability of the cell membrane can affect drug resistance in cancer. Research has shown that cancer cells often have changes in the fluidity and permeability of their cell membrane that contribute to their resistance to drugs used to treat cancer. These changes may be due to changes in the composition and organization of the lipid bilayer that makes up the membrane, as well as changes in the expression or localization of proteins and other molecules embedded in the membrane. The lipid composition in the tumor cell membrane changes with drug resistance, which can affect the fluidity and permeability of the cell membrane. Reversal of drug resistance can be achieved by altering cell membrane fluidity and permeability. In recent years, there have been numerous studies aimed at understanding the mechanisms underlying these changes and identifying strategies to overcome drug resistance in cancer. This research has led to the development of new drugs and drug delivery systems that are designed to target specific changes in the cell membrane of cancer cells and improve the effectiveness of chemotherapy. Overall, the advances in our understanding of the role of cell membrane fluidity and permeability in drug resistance in cancer have led to the development of new approaches to treat cancer and improve patient outcomes and further research is needed to continue to improve the understanding of these mechanisms and to identify new strategies to overcome drug resistance in cancer. This article highlights the research status and detection methods of cell membrane fluidity and permeability affecting tumor drug resistance.

9 January 2024 in Columbia Undergraduate Science Journal
Verified
Journal Article
Open access
PDF file
Neelabh DattaNeelabh Datta
Neelabh Datta
Huntington disease (HD) is a fatal genetic disorder that affects the movement and cognition of affected individuals. It is inherited in an autosomal dominant manner, meaning that each child of a parent with HD has a 50% chance of inheriting the mutated gene. The mutation involves an expansion of a trinucleotide repeat (CAG) in the HD gene, which is located on the short arm of chromosome 4p16.3. The HD gene encodes a protein called huntingtin, which has an unknown function. The number of CAG repeats determines the severity and onset of the disease. Normal individuals have 26 or fewer repeats, while HD patients have 40 or more repeats. Individuals with 27 to 35 repeats do not develop HD, but they can pass on the mutation to their offspring, especially if the mutation is inherited from the father. Individuals with 36 to 39 repeats may or may not develop HD, depending on other factors. The more CAG repeats, the earlier the symptoms appear. HD is the most extensively studied neurodegenerative disorder with a genetic cause. There are genetic tests available to diagnose HD and to predict the risk of developing HD in asymptomatic individuals. There are also prenatal and preimplantation tests to prevent the transmission of HD to the next generation. HD is characterized by involuntary movements called chorea, which affect all muscles and impair all psychomotor functions. HD patients also suffer from cognitive decline and psychiatric symptoms, such as mood disorders and social changes. These symptoms are chronic and progressive, leading to complete dependence and death. Chorea can also be caused by other conditions, such as metabolic disorders or drug-induced side effects. Neuroimaging techniques, such as MR imaging, fluorodeoxyglucose positron emission tomography (FDG-PET), MR spectroscopy, and diffusion tensor imaging, can help to diagnose HD and monitor its progression. The pathophysiology of HD involves the loss of neurons and the dysfunction of neurotransmitter systems, especially the dopaminergic system. There is no cure for HD, but there are treatments to manage the symptoms and to improve the quality of life of HD patients. These include pharmacological interventions, such as dopamine receptor antagonists or depleters, and non-pharmacological interventions, such as psychological and social support. HD is a devastating disease that poses many challenges for patients, families, and healthcare providers. There is hope that gene-targeted therapies will be developed in the near future to stop or slow down the disease process.

31 May 2024 in Indian Journal of History of Science
Verified
Journal Article
Closed access
PDF file
Neelabh DattaNeelabh Datta
Neelabh Datta